Now Enrolling Patients in Phase 2 study

Phase 2 trial is now enrolling patients in 50 centers involving 102 patients worldwide.  This is a 24 week long study involving 8 clinic visits. Principal Investigators in Canada: Dr. Catherine Vincent, Montreal; Dr. Giada Sebastiani, Montreal  Dr. Mark Swain, Calgary; Dr. Gerald Minuk, Winnipeg.  More details about the trial here.